Using Shear Wave Ultrasound Elastography for Follow up After Anti-spastic Intervention Among Stroke Patients
1 other identifier
observational
100
1 country
1
Brief Summary
Spasticity of stroke patient, a very common complication in clinical practice, affects performance of hand function and gait pattern. It also interferes with quality of life of patients severely. Currently first line clinical approach to spasticity consist of physical therapy and pharmacological management. However, there are still some refractory cases that needed local intervention such as Botox injection. So far, we only can use subjective methods to measure muscle tension, such as modified Ashworth scale and Tone Assessment Scale. In our previous study, we found that ultrasound shear wave image could correlate with muscle stiffness caused by poststroke spasticity. With this new method, we aim to establish a more objective method in measuring abnormal poststroke muscle tension before and after treatments and further monitor therapeutic effect. We also include several assessment scales to evaluate the correlation between measured muscle spasm and activity of daily living. We hypothesize that the rheological changes in muscles muscle spasm after Botox injection can be detected by ultrasound shear wave image. Therapeutic effect can also be seen in its effect on daily functions. In this project, we will use shear wave imaging of ultrasound to investigate the elasticity (and hardness) of the biceps brachii and brachialis muscle in stroke patients with unilateral hemiplegia before and after Botox injection. The findings of this project will provide the objective evaluation of muscle spasticity and its correlation with functional status, which will provide new points of view toward treatment of spasticity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2020
CompletedFirst Submitted
Initial submission to the registry
September 9, 2020
CompletedFirst Posted
Study publicly available on registry
September 16, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2021
CompletedSeptember 16, 2020
July 1, 2020
1.2 years
September 9, 2020
September 9, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Shear Wave Ultrasound Elastography
Shear wave ultrasound elastography measurement of spastic upper limb muscles, including biceps brachii and brachialis
During each follow up visit within 12 weeks time frame
Secondary Outcomes (10)
Barthel Index (Wade's version)
During each follow up visit within 12 weeks time frame
Revised Nottingham Extended Activities of Daily Livings Scale
During each follow up visit within 12 weeks time frame
Stroke Rehabilitation Assessment of Movement (STREAM), brief version
During each follow up visit within 12 weeks time frame
Modified Ashworth Scale (MAS)
During each follow up visit within 12 weeks time frame
Tone Assessment Scale (TAS)
During each follow up visit within 12 weeks time frame
- +5 more secondary outcomes
Study Arms (2)
Intervention
The stroke patients who receive botulinum toxin injection at affected brachialis and/or biceps brachials.
Control
The stroke patients who do not receive botulinum toxin injection at affected brachialis and/or biceps brachials in the past 3 months.
Interventions
Botulinum toxin injection at affected brachialis and/or biceps brachials.
Eligibility Criteria
Stroke patient aged above 20 years old with unilateral involvement.
You may qualify if:
- \[Intervention group\]
- Stroke patients with unilateral involvement
- Patient's spasticity over affected upper extremities scored at least 1+ with Modified Ashworth Scale
- Patient required botulinum toxin injection at affected upper limb muscle per primary care physician.
- \[Control group\]
- Stroke patients with unilateral involvement
- Patient's spasticity over affected upper extremities scored at least 1+ with Modified Ashworth Scale
You may not qualify if:
- Patients ever diagnosed with cerebral diseases other than stroke, such as traumatic brain injury, encephalitis and brain tumor
- Patients failed to cooperated due to cognition, consciousness or speech problem
- Patients with illness that could affect muscle stiffness, such as spinal cord injury and Parkinson's disease
- Patients with upper limb contracture
- Patients receiving botulinum toxin injection or shock wave therapy over upper extremities during past three months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University Hospital
Taipei, 100, Taiwan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Huey-Wen Liang, MD PHD
National Taiwan University Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 12 Weeks
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 9, 2020
First Posted
September 16, 2020
Study Start
September 1, 2020
Primary Completion
December 1, 2021
Study Completion
December 1, 2021
Last Updated
September 16, 2020
Record last verified: 2020-07
Data Sharing
- IPD Sharing
- Will not share